Alexander Kolevzon, MD
img_Alexander Kolevzon
PROFESSOR | Psychiatry
PROFESSOR | Pediatrics
Are you a patient?
Specialties
Psychiatry, Child and Adolescent Psychiatry
Research Topics
Autism, Behavioral Health, Personalized Medicine, Pharmacology, Psychiatry
Dr. Kolevzon's research interests include the biological causes and effective treatment of autism and related pervasive developmental disorders. He is also committed to medical student and residency training and education and interested in developing innovative educational programs.

MD, Sackler School of Medicine (Tel Aviv University)

MD, Tel Aviv University

Residency, Psychiatry, Icahn School Of Medicine At Mount Sinai

Fellowship, Psychiatry & Neurology, Child & Adolescent Psychiatry, Icahn School Of Medicine At Mount Sinai

2020

RARE Champion of Hope Award

Global Genes

2012

Teacher of the Year Award in Child and Adolescent Psychiatry

Division of Child and Adolescent Psychiatry, Mount Sinai

2011

Outstanding Mentor Award

American Academy of Child and Adolescent Psychiatry

2007

Excellence in Teaching Award

2006

Junior Faculty Development Award

Association of Academic Psychiatry

2005

AACAP Pilot Research Award

2003

Richard L. Scharf Memorial Award for Teaching Excellence

2003

Outstanding Child and Adolescent Psychiatry Resident Award

American Academy of Child and Adolescent Psychiatry

2002

Outstanding Resident Award

National Institute of Mental Health

2001

Alpha Omega Alpha (AOA)

2001

Teacher of the Year Award in General Psychiatry

Department of Psychiatry, Mount Sinai

Employee Spotlight - Alex Kolevzon, MD

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Kolevzon during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • cureshank
  • Klingenstein Third Generation Foundation
  • Jaguar Gene Therapy
  • Butler Snow, LLP
  • David Lynch Foundation
  • Scioto Biosciences
  • Clinilabs Drug Development Corporation
  • Covington and Burling, LLP
  • Acadia
  • Ritrova Therapeutics
  • PYC Therapeutics
  • biogen
  • Ovid Therapeutics

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.